The Annual Israeli Cystic Fibrosis Society Conference- Webinar Meeting
Session 1
Chair: Inbal Golan-Tripto; Soroka Medical Center, Beer Sheva
11:00-11:05 Congress Opening and Greetings
Malena Cohen-Cymberknoh, MD
Pediatric Pulmonary Unit and CF Center,
Hadassah-Hebrew University Medical Center, Jerusalem
11:05-11:20 Comparison of CF patients carrying residual function mutations with patients homozygous for minimal function mutations - Data from the European CF Registry
Meir Mei Zahav, MD
Pediatric Pulmonary Institute and Graub CF Center,
Schneider Children's Medical Center, Petah Tikva
11:20- 11:35 Baseline CF disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression
Bar Gindi Reiss, MD
Faculty of Medicine, Hebrew University,
and CF Center, Hadassah-Hebrew University Medical Center, Jerusalem
11:35- 11:50 Advanced Cystic Fibrosis – crossroads in care
Joel Weinberg, MD
CF Center,
Schneider Children's Medical Center and Beilinson Hospital, Petah Tikva
11:50-12:05 Outcomes of persistent inflammation after pseudomonas eradication in early CF
Oded Breuer, MD
Pediatric Pulmonary Unit and CF Center,
Hadassah-Hebrew University Medical Center, Jerusalem
12:05 – 12:20 The old and the new in inhaled antibiotic therapy
Michal Shteinberg, MD
Pulmonary Unit and CF Center,
Carmel Medical Center, Haifa
12:20-12:35 Gastrointestinal outcome measures before and after TRIKAFTA therapy in CF patients carrying the F508del mutation
Michael Wilschanski, MD
Pediatric Gastroenterology Unit and CF Center,
Hadassah-Hebrew University Medical Center, Jerusalem
12:35 – 12:50 Social work in the shadow of COVID19 (talk in Hebrew)
Dr. Friedman Rachel and Mery Fasja, MSW
CF Centers of Carmel Medical Center and Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer
12:50-13:20 LUNCH
Session 2
Chair: Joel Reiter, MD; Hadassah Medical Center, Jerusalem
13:20- 13:35 The Israeli CF Database - 2018
Meir Mei Zahav, MD
Pediatric Pulmonary Unit and Graub CF Center,
Schneider Children's Medical Center, Petah Tikva
13:35-13:45 Trikafta- a tale of one patient
Michal Gur, MD
Pediatric Pulmonology Unit and CF Center,
Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa
13:45-14:00 Triple combination therapy- The Israeli experience
Adi Dagan, MD
Pediatric Pulmonary Unit and CF Center,
Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer
14:00-14:25 Restoring CFTR function from early life: what can we expect to achieve?
Jane Davies, MD
Paediatric Respirology & Experimental Medicine, National Heart & Lung Institute, Imperial College London, Royal Brompton & Harefield NHS Foundation Trust, London, UK
14:25- 14:40 Anti-Sense Oligonucleotides (ASOs) as splicing modulators in organoids – novel insights into a potential therapy
Noemie Stanleigh, PhD
Department of Genetics, Life Sciences Institute, Hebrew University, Jerusalem
14:40-14:55 CFTR Restoration by ELX-02 Across CF Nonsense Genotypes: Utilizing Patient-Derived Organoids to Survey Responsive Alleles
Matt Goddeeris, PhD
Vice President, Research, Eloxx Pharmaceuticals
14:55-15:20 Cell Therapy for CF
Scott H. Randell, PhD
Marsico Lung Institute (MLI) Tissue Procurement and Cell Culture Core; UNC-Chapel Hill, North Carolina
15:20-15:35 Anxiety in the Reign of Corona
Dr. Eddie Landau
Graub CF Center,
Schneider Children's Medical Center, Petah Tikva
15:35 Closing remarks
Malena Cohen-Cymberknoh, MD, Hadassah Medical Center and
Eitan Kerem, MD, Head, The Israeli Cystic fibrosis Society